P1119: CAMRELIZUMAB PLUS LOW-DOSE APATINIB AND PEGASPARGASE FOLLOWED BY RADIOTHERAPY FOR NEWLY DIAGNOSED STAGE I/II NATURAL KILLER/T-CELL LYMPHOMA: A PROSPECTIVE MULTICENTER SINGLE...

por Zhi-Ming, LI, Liu, Chuanxu, Sun, Peng, Tian, Shu, Ding, Hao, Tao, Rong
Publicado 2023

P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY

por Zhi-Ming, LI, Sun, Peng, Cen, Hong, Yang, Hai-Yan, Huang, Rui, Cai, Zhen, Gu, Xue-Kui
Publicado 2023

P1190: EFFICACY AND SAFETY OF SELINEXOR COMBINING WITH R-CHOP IN THE TREATMENT OF NEWLY DIAGNOSED HIGH RISK (IPI 3-5) GCB SUBTYPE DLBCL PATIENTS: A MULTICENTER RETROSPECTIVE REAL-W...

por Zhi-Ming, LI, Yang, Hang, Yin, Yanxue, LI, Yajun, Zhou, Shiyong, Sun, Peng, Wang, Yu, Zhang, Lu, Zhou, Hui, Zhang, Huilai
Publicado 2023